Chlorpromazine equivalent doses for the newer atypical antipsychotics.
about
A systematic examination of brain volumetric abnormalities in recent-onset schizophrenia using voxel-based, surface-based and region-of-interest-based morphometric analysesEfficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysisCorpus callosum abnormalities and their association with psychotic symptoms in patients with schizophreniaDownregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patientsA theory of mind investigation into the appreciation of visual jokes in schizophreniaThe effect of verbalization strategy on Wisconsin Card Sorting Test performance in schizophrenic patients receiving classical or atypical antipsychotics.Increased Resting-State Gamma-Band Connectivity in First-Episode SchizophreniaThe Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-AnalysisA longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophreniaThe effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophreniaInvestigating Cortical Inhibition in First-Degree Relatives and Probands in SchizophreniaActivation and Functional Connectivity of the Left Inferior Temporal Gyrus during Visual Speech Priming in Healthy Listeners and Listeners with Schizophrenia.Amusia and protolanguage impairments in schizophrenia.Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia.Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.Mild expression differences of MECP2 influencing aggressive social behavior.Electrophysiological assessment of auditory stimulus-specific plasticity in schizophreniaA neurophysiological deficit in early visual processing in schizophrenia patients with auditory hallucinations.When to hold that thought: an experimental study showing reduced inhibition of pre-trained associations in schizophrenia.Gamma band neural synchronization deficits for auditory steady state responses in bipolar disorder patientsERP generator patterns in schizophrenia during tonal and phonetic oddball tasks: effects of response hand and silent countGetting the cue: sensory contributions to auditory emotion recognition impairments in schizophrenia.Sensorimotor gating of schizophrenia patients depends on Catechol O-methyltransferase Val158Met polymorphismCurrent source density (CSD) old/new effects during recognition memory for words and faces in schizophrenia and in healthy adultsAberrant functional organization and maturation in early-onset psychosis: evidence from magnetoencephalography.Sensory-evoked gamma oscillations in chronic schizophrenia.Linking social cognition with social interaction: Non-verbal expressivity, social competence and "mentalising" in patients with schizophrenia spectrum disorders.Olanzapine improves deficient sensory inhibition in DBA/2 mice.Gamma-band auditory steady-state responses are impaired in first episode psychosis.The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study.Elevated functional connectivity along a corticostriatal loop and the mechanism of auditory/verbal hallucinations in patients with schizophrenia.Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studiesNeuronal generator patterns of olfactory event-related brain potentials in schizophrenia.Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011Prospective cohort study of the relationship between neuro-cognition, social cognition and violence in forensic patients with schizophrenia and schizoaffective disorder.Failure to mobilize cognitive control for challenging tasks correlates with symptom severity in schizophreniaComparing fractional anisotropy in patients with childhood-onset schizophrenia, their healthy siblings, and normal volunteers through DTIMetacognitive training for delusions (MCTd): effectiveness on data-gathering and belief flexibility in a Chinese sample.Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.
P2860
Q24288871-4D2FBD95-CD6E-40D8-B744-8222C0854160Q24606868-C55A84E2-8E84-4F07-8DDC-4DEEC3CE04B8Q24616310-8C9BC3B9-AA8B-41E7-92C6-07BED14941F5Q24631189-9F9F7F86-FB14-4392-A96E-CE409771E468Q24633061-3EC37DE3-11F0-4BE0-8A63-451B84E13E72Q24801147-83DA30A3-4411-4BFB-81AC-CCFA83EDDD35Q25256710-C6DD5842-9FC2-468F-8439-C452976C4F76Q27320037-9FB44444-1F26-468B-81BF-84784436DD5DQ28066603-21B63256-335C-462F-9960-84DBF8B14F63Q28539784-8F0EB8BA-059C-427C-92FD-62721C412ABFQ28742079-2DF6235B-F7F8-4E1C-9AD7-92678758C770Q30358965-9DB40DAD-3D37-44F3-85F7-90CA11E74BA3Q30360113-9B9EADC9-B340-460A-BA64-4A3E51C8AD6CQ30360155-4DEADB17-E3B8-4D74-8680-5EE3BCAA1103Q30365000-8806A266-89C9-468A-856F-64D788E935DDQ30373174-15AE5A31-6A1B-458E-A8B9-CFBA2409E594Q30438103-BA388924-F22F-46F2-8EBA-5FA012B012F6Q30449596-371E3C89-3D23-42A2-84C7-BA38F4A1A21FQ30450069-40DCFB05-13FA-4C2A-85A5-67B15355AEDFQ30464994-E3AF1741-1D21-4F98-BB99-B4A80C8E046FQ30465769-ED16094C-B164-4B57-8BF3-DED65C48E5B4Q30467984-7CACD8B3-9B65-4414-A1D9-A26DB6F31A7CQ30475715-D230ECDE-EBEA-464F-8898-7BD427EC8224Q30476817-468D48D9-C11B-439D-86EC-2BF2A2372028Q30477271-C15CE530-1EBE-4308-BD9D-DF32B32785AEQ30480337-162AD02A-6737-4B6A-8AF7-1F9F0B2C6265Q30481764-2C910D17-3D46-4556-A495-09CF948973EEQ30485865-538EE8E2-DC33-40CB-AAC9-FF9E8E3042BCQ30486196-C354BE76-25BA-4DF9-9AFF-468A2FC8278AQ30487085-69431BF2-FA9E-4924-B070-FC7D45538921Q30490077-D13CCE0E-6470-4CF5-99C1-00EF195CC940Q30498185-F8F7F987-7DDA-4FC2-98C1-FBB11EA1AECCQ30513499-768F374A-EE2D-42C5-A752-E48EF3806C21Q30513909-FF05B6EF-9C90-4335-A5B9-4F6A56C809D0Q30650589-BC1AB306-49F1-42E9-AFBF-900F597DAF6BQ30657237-37F1B117-1C89-47D2-907C-300F8053327DQ30828715-0D870490-B7EA-4BCC-BEA5-11D673C14DFAQ30850987-C70F3F7C-6BB7-48C9-8468-53A328BAD1FAQ30977624-D4C19DA0-81D6-404D-82CB-E3F3D2AF1EC4Q33248004-43CF76EB-AB66-4588-82B2-FCF8F025BA4A
P2860
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@ast
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@en
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@nl
type
label
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@ast
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@en
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@nl
prefLabel
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@ast
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@en
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@nl
P1476
Chlorpromazine equivalent doses for the newer atypical antipsychotics.
@en
P2093
Scott W Woods
P304
P577
2003-06-01T00:00:00Z